中肝合剂为我院制剂，过去主要用于治疗化疗药物对肝脏的损害。1995年2月至1997年10月观察48例住院病人；年龄23岁-56岁，中位年龄38．7岁，其中男32例（肺癌术后），女16例（乳腺癌术后，男女均经病理证实），分为单纯化疗组（化疗组）和化疗合用中肝合剂组（预防组）。化疗组 Zhonggan Mixture is the preparation of our hospital. In the past, it was mainly used to treat the liver damage caused by chemotherapy drugs. From February 1995 to October 1997, 48 inpatients were observed; aged 23 to 56 years, median age 38.7 years, including 32 males (postoperative lung cancer) and 16 females (postoperative breast cancer, male and female All were pathologically confirmed), divided into chemotherapy alone group (chemotherapy group) and chemotherapy combined with liver mixture group (prevention group). Chemotherapy group